SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-079293
Filing Date
2023-03-24
Accepted
2023-03-24 17:28:02
Documents
12
Period of Report
2023-03-23
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d453945d8k.htm   iXBRL 8-K 44197
  Complete submission text file 0001193125-23-079293.txt   172944

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mtcr-20230323.xsd EX-101.SCH 2502
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtcr-20230323_lab.xml EX-101.LAB 18782
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtcr-20230323_pre.xml EX-101.PRE 11696
6 EXTRACTED XBRL INSTANCE DOCUMENT d453945d8k_htm.xml XML 3679
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39512 | Film No.: 23760880
SIC: 2834 Pharmaceutical Preparations